View Document Preview and Link Document Date: 2014-07-04 02:02:05 Open Document File Size: 123,56 KB Share Result on Facebook
City Basel / / Company Ventana Medical Systems Inc. / Roche Group / Japan Clinical Oncology Group / Chugai Pharmaceutical / Chugai Kamakura Research Laboratories / Genentech / F. Hoffmann-La Roche Ltd / / Continent Europe / / Country Switzerland / Japan / United States / / Currency CHF / / / Event FDA Phase / / / IndustryTerm pharmaceuticals / diabetes management / research-focused healthcare / / MedicalCondition tissue-based cancer / serious diseases / Cancer / brain metastases / disease / NSCLC / NSCLC whose tumours / neutropenia / diabetes / anaplastic lymphoma kinase fusion / small-cell lung cancer / lung cancer / ALK+ lung cancer / non-small cell lung cancer / infectious diseases / advanced nonsmall cell lung cancer / lung cancer Lung cancer / adenocarcinoma / tumours / / MedicalTreatment antibiotics / chemotherapy / surgery / / Organization World Health Organization / World Congress / U.S. Food and Drug Administration / Ministry of Health / / Person Nina Schwab-Hautzinger / Claudia Schmitt / Sandra Horning / Nicolas Dunant / Ulrike Engels-Lange / Schwab-Hautzinger References / / / Position leader / majority shareholder / Chief Medical Officer and Head of Global Product Development / Head / / Product CH5424802 / / Technology neuroscience / chemotherapy / in vitro diagnostics / / URL http / SocialTag 
Microsoft Word - 140704_Alectinib Japan Launch_Final_en